Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 291 participants.
Also called NCT01515228
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 291 participants
- Registry
-
NCT01515228
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01515228. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Xience Prime
- Intervention (Device)
- Cilotax stent
- Lead sponsor
- CHEOL WHAN LEE, MD, PhD.
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct01515228- Content hash
6518fb9d19caa075704da65ff192abdbcc6841ae8c772108c7820e8744ea81c2